Android app Apple app link

Teva reports positive outcomes from episodic migraine trial in young patients

By Yahoo! Finance   |   3 months ago
Teva reports positive outcomes from episodic migraine trial in young patients

Teva Pharmaceutical Industries found positive results in the Phase III SPACE trial of Ajovy for episodic migraine in young patients aged 6-17. The trial showed significant reduction in migraine frequency with a good safety profile, indicating potential benefits for children and adolescents suffering from migraines.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.